Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587678 · ClinicalTrials.gov registry record · NA
Comprehensive Magnetic Resonance of Peripheral Arterial Disease
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT00587678: Completed NA study, sponsored by University of Virginia.
NCT00587678 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587678, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.
Primary Outcome
SFA plaque volume
Interventions
- DRUG Simvastatin
- DRUG Ezetimibe
- DRUG Simvastatin/Ezetimibe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00587678 record still lists
NCT00587678 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Simvastatin is the first listed.
NCT00587678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00587678 about?
NCT00587678 is a clinical study titled "Comprehensive Magnetic Resonance of Peripheral Arterial Disease". The purpose of this study is to develop new ways of imaging fatty blockages in the leg arteries to improve upon techniques used now and to develop new ways of understanding how new treatments may affect the disease.
What is the current status of trial NCT00587678?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2006-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00587678?
The interventions under investigation include: Simvastatin (DRUG), Ezetimibe (DRUG), Simvastatin/Ezetimibe (DRUG).
Who is sponsoring clinical trial NCT00587678?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00587678's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia